Yahoo Web Search

  1. U.S. drugmaker Bristol-Myers Squibb Co reported higher-than-expected third-quarter profit on Thursday, helped by strong sales of blood thinner Eliquis, even as growth of ...

  2. Shares of Bristol-Myers Squibb (BMY) have been strong performers lately, with the stock up 15.8% over the past month. Bristol-Myers Squibb has gained ...

  3. Should You Buy Bristol-Myers (BMY) Ahead of Earnings?

    Zacks via Yahoo FinanceOct 30 12:32 PM

    Investors are always looking for stocks that are poised to beat at earnings season and Bristol-Myers Squibb Company BMY may be one such company. In fact, the ...

  4. Bristol-Myers’ BMY immuno-oncology drug, Opdivo, which is approved for multiple oncology indications fueled the top line in the second quarter. The uptake of the drug continued ...

  5. 3 Reasons Growth Investors Will Love Bristol-Myers (BMY)

    Zacks via Yahoo FinanceNov 01 12:45 PM

    Bristol-Myers Squibb (BMY) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks ...

  6. Stocks recently featured in the blog include: Pfizer PFE, Merck MRK, Bristol-Myers BMY and Glaxo GSK. Pfizer, Merck, Bristol-Myers, Glaxo and Bayer released their ...

  7. Bristol-Myers: 3Q Earnings Snapshot

    Associated Press via Yahoo FinanceOct 31 11:18 AM

    Bristol-Myers Squibb Co. (BMY) on Thursday reported third-quarter profit of $1.35 billion. The New York-based company said it had net income of 83 cents per share ...

  8. Company News for Nov 1, 2019

    Zacks via Yahoo FinanceNov 01 14:32 PM

    TWTR fell 0.4% after the company said that it will ban political advertising on its platform from the upcoming month Shares of Bristol-Myers Squibb Company ...

  9. Bristol-Myers Squibb Company BMY announced that the FDA has accepted and granted priority review designation to a supplemental Biologics License Application (sBLA ...

  10. We wouldn't blame Bristol-Myers Squibb Company (NYSE:BMY) shareholders if they were a little worried about the fact that John Elicker, the Senior Vice President of ...